Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2750
Single User License Price INR 189750
Corporate User License Price USD 4500
Corporate User License Price INR 310500
Site License Price USD 3500
Site License Price INR 241500
Request a Quote

Report Title

Neurodiagnostics Market

Quote Request for License Type
License Type Price  
Single User License USD 2750
Site License USD 3500
Enterprise Wide License USD 4500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Neurodiagnostics Market


Quote Request for License Type
License Type Price  
Single User License USD 2750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Neurodiagnostics Market

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Neurodiagnostics Market



Executive Summary

Global Neurodiagnostics Market Forecast up to 2025

[110 pages report] This market research report includes a detailed segmentation of the global neurodiagnostics market by technology [neuroimaging technologies (computed tomography (CT), nuclear medicine imaging (NMI), magnetic resonance imaging (MRI), electroencephalography (EEG), magnetoencephalography (MEG), near infrared spectroscopic imaging (NIRS) and voxel-based morphometry), in vitro diagnostics, and neuroinformatics] and by regions [North America, Europe, APAC and RoW].

Overview of the Global Neurodiagnostics Market Research

Infoholic's market research report predicts that the global neurodiagnostics market will grow at a CAGR of 7.5% during the forecast period. The market has witnessed steady growth in the past few years, and the development in technology with the introduction of advanced products has increased the acceptance of neurodiagnostics products in the market. The market is fueled by the growing adoption of novel diagnostics technologies, upsurge in the number of patients with neurological diseases, and increasing aging population.

Imaging and in vitro diagnostics are the most widely used technologies for the diagnosis of mental health disorders. This particular field is getting revolutionized with the advancement in technology. Globally, there are around dozens of 7-T machines in research labs, and the first 7-T model was cleared for clinical use in 2018. Vendors are focusing on new product launches and targeting toward end user's perspective. The revenue is generated from the key players operating in this field, and few of them include GE Healthcare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems Corporation, Hitachi Medical Corporation, and Nihon Kohden Corporation.

According to Infoholic Research analysis, North America accounted for the largest share of the global neurodiagnostics market in 2018 and will retain a high position during the forecast period. The region has the highest percentage of the geriatric population with a growing prevalence of neural diseases such as Parkinson disease, epilepsy, migraine, and stroke. Further, the availability of advanced technologies is driving the market growth in North America. The Asia Pacific region is expected to witness the fastest growth rate due to the increasing patient pool, growing awareness among patients, and rising healthcare expenditure.

By Technology:

Neuroimaging Technologies

? Computed Tomography (CT)

? Nuclear Medicine Imaging (NMI)

? Magnetic Resonance Imaging (MRI)

? Electroencephalography (EEG)

? Magnetoencephalography (MEG)

? Near-infrared Spectroscopic Imaging (NIRS)

? Voxel-based Morphometry (VBM)

In Vitro Diagnostics

Neuroinformatics

In 2018, the neuroimaging technologies segment occupied the largest share and is expected to remain the same during the forecast period. Among various neuroimaging technologies, CT and MRI are the two key imaging modalities commonly used to identify brain anomalies. The neuroinformatics segment is anticipated to grow at a high CAGR during the forecast period.

By Regions:

North America

Europe

APAC

ROW

The market is dominated by North America, followed by Europe and Asia Pacific. The US occupied the dominant share in North America due to the rapid adoption of new and advanced diagnostic technologies.

Neurodiagnostics Market Research Competitive Analysis-The global neurodiagnostics market has massive growth opportunities in both developed and developing regions. The advancements and upgradation of technology will increase the competition among vendors. Many vendors are focusing on developing innovative products to strengthen their product portfolio that intensifies the market competition. In January 2018, Brain Vision Solutions launched LiveAmp 64, a high-density wireless EEG solution that can be used with a wide range of innovative electrode technologies and also, there is an easy upgrade path all the way from 8 to 64 channels. Nihon Kohden launched its airEEG WEE-1200 wireless EEG system in March 2018, and it is designed specifically for patient comfort and easy access to real-time patient data during long-term epilepsy monitoring.

GE Healthcare introduced its range of MRI contrast media products with the launch of macrocyclic agent Clariscan in Europe in March 2017. Canon Medical Systems launched its next-generation 80-row multi-slice CT scanner, Aquilion Prime SP, at UKRC in 2017. The company has also initiated collaborative research in March 2018 on the application of Artificial Intelligence (AI)-based technology in MR imaging, together with Kumamoto University and the University of Bordeaux. In addition, other leading players are focusing on investing heavily in R&D activities to develop new products to attain a maximum share in the market.

Key vendors:

GE Healthcare

Siemens Healthineers

Philips Healthcare

Canon Medical Systems Corporation

Hitachi Medical Corporation

Nihon Kohden Corporation

Fonar Corporation

Neusoft Medical Systems Co., Ltd.

NeuroNexus Technologies, Inc.

Lifelines Neurodiagnostic Systems, Inc.

NeuroDx Development

Bruker Corporation

Plexon Inc

Natus Medical Incorporated

Key competitive facts

The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices are key factors that confront the market.

The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.

Benefits-The report provides complete details about the usage and adoption rate of neurodiagnostics products. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives toward the diagnostics segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

Understanding the potential market opportunity with precise market size and forecast data.

A detailed market analysis focusing on the growth of the neurodiagnostics industry.

Factors influencing the growth of the neurodiagnostics market.

In-depth competitive analysis of dominant and pure-play vendors.

Prediction analysis of the neurodiagnostics industry in both developed and developing regions.

Key insights related to major segments of the neurodiagnostics market.

The latest market trend analysis impacting the buying behavior of the consumers.

Key Stakeholders

Table of Contents

1 Industry Outlook 10

1.1 Industry Overview 10

1.2 Total Addressable Market 10

1.3 Industry Trends 11

2 Report Outline 13

2.1 Report Scope 13

2.2 Report Summary 13

2.3 Research Methodology 14

2.4 Report Assumptions 14

3 Market Snapshot 16

3.1 Market Definition-Infoholic Research 16

3.2 Types of Neurological Diseases 16

3.3 Causes of Neurological Diseases 16

3.4 Signs of Neurological Disorders 17

3.5 Distinctive Neurological Procedures 17

3.6 Segmented Addressable Market 17

3.7 Key Trends in the Neurodiagnostics Market 18

3.8 Related Markets 19

3.8.1 Parkinson's Diseases 19

3.8.2 Neurointerventional Devices 20

3.8.3 Neurosurgical Devices 22

4 Market Outlook 24

4.1 Market Segmentation 24

4.2 PEST Analysis 24

4.3 Porter 5(Five) Forces 25

5 Market Characteristics 27

5.1 DRO Analysis-Market Dynamics 27

5.1.1 Drivers 27

5.1.1.1 Increasing number of patients with neurological diseases 27

5.1.1.2 Increasing aging population 28

5.1.1.3 Growing adoption of novel diagnostic technologies 29

5.1.2 Opportunities 29

5.1.2.1 Upsurge in the introduction of new products and recent product approvals 29

5.1.2.2 Advancement in technology 30

5.1.3 Restraints 30

5.1.3.1 High cost of diagnosis 30

5.1.3.2 Lack of trained professionals 31

5.2 DRO-Impact Analysis 31

5.3 Key Stakeholders 32

6 Technologies: Market Size and Analysis 33

6.1 Overview 33

6.2 Neuroimaging 34

6.2.1 Computed Tomography 35

6.2.2 Magnetic Resonance Imaging 37

6.2.3 Nuclear Medicine Imaging 38

6.2.4 Near Infrared Spectroscopic Imaging 39

6.2.5 Electroencephalography 40

6.2.6 Magnetoencephalography 41

6.2.7 Voxel-based Morphometry 42

6.3 In Vitro Diagnostics 43

6.4 Neuroinformatics 44

7 Regions: Market Size and Analysis 46

7.1 Overview 46

7.2 North America 47

7.3 Europe 49

7.4 Asia Pacific 51

7.5 Rest of the World 52

8 Competitive Landscape 54

8.1 Overview 54

9 Vendors Profile 57

9.1 GE Healthcare 57

9.1.1 Overview 57

9.1.2 Business Units 61

9.1.3 Geographic Presence 63

9.1.4 Business Focus 63

9.1.5 SWOT Analysis 64

9.1.6 Business Strategies 64

9.2 Hitachi Medical Corporation 65

9.2.1 Overview 65

9.2.2 Business Units 67

9.2.3 Geographic Presence 69

9.2.4 Business Focus 69

9.2.5 SWOT Analysis 70

9.2.6 Business Strategies 70

9.3 Siemens Healthineers 71

9.3.1 Overview 71

9.3.2 Business Units 74

9.3.3 Geographic Presence 76

9.3.4 Business Focus 76

9.3.5 SWOT Analysis 77

9.3.6 Business Strategies 77

9.4 Philips Healthcare 78

9.4.1 Overview 78

9.4.2 Business Units 83

9.4.3 Geographic Presence 83

9.4.4 Business Focus 84

9.4.5 SWOT Analysis 85

9.4.6 Business Strategies 85

9.5 Canon Medical Systems Corp. 86

9.5.1 Overview 86

9.5.2 Business Units 88

9.5.3 Geographic Presence 89

9.5.4 Business Focus 90

9.5.5 SWOT Analysis 90

9.5.6 Business Strategies 91

9.6 Nihon Kohden Corporation 92

9.6.1 Overview 92

9.6.2 Business Units 94

9.6.3 Geographic Presence 95

9.6.4 Business Focus 96

9.6.5 SWOT Analysis 96

9.6.6 Business Strategies 97

10 Companies to Watch For 99

10.1 Bruker Corporation 99

10.1.1 Overview 99

10.1.2 Recent Developments 100

10.2 Fonar Corporation 101

10.2.1 Overview 101

10.2.2 Recent Developments 102

10.3 NeuroNexus Technologies 102

10.3.1 Overview 102

10.3.2 Recent Developments 103

10.4 Neusoft Medical Systems Co. Ltd. 103

10.4.1 Overview 103

10.4.2 Recent Developments 104

10.5 Plexon Inc. 104

10.5.1 Overview 104

10.5.2 Recent Developments 105

10.6 Lifelines Neurodiagnostics Systems Inc. 105

10.6.1 Overview 105

10.6.2 Recent Developments 106

10.7 Natus Medical 106

10.7.1 Overview 106

10.7.2 Recent Developments 107

10.8 NeuroDx Development 107

10.8.1 Overview 107

10.8.2 Recent Developments 108

11 Annexure 109

11.1 Abbreviations 109

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL NEURODIAGNOSTICS MARKET 14

CHART 2 GLOBAL NEURODIAGNOSTICS MARKET REVENUE, 2018-2025 (USD MILLION) 18

CHART 3 GLOBAL NEURODIAGNOSTICS MARKET BY SEGMENTATION 24

CHART 4 PEST ANALYSIS OF GLOBAL NEURODIAGNOSTICS MARKET 24

CHART 5 PORTER 5 FORCES ON GLOBAL NEURODIAGNOSTICS MARKET 25

CHART 6 MARKET DYNAMICS-DRO ANALYSIS 27

CHART 7 DRO-IMPACT ANALYSIS OF GLOBAL NEURODIAGNOSTICS MARKET 31

CHART 8 KEY STAKEHOLDERS 32

CHART 9 GLOBAL NEURODIAGNOSTICS MARKET BY TECHNOLOGY SEGMENTATION, 2018 (%) 33

CHART 10 GLOBAL NEURODIAGNOSTICS MARKET BY TECHNOLOGY SEGMENTATION, 2025 (%) 33

CHART 11 GLOBAL NEUROIMAGING MARKET FORECAST, 2018-2025 (USD MILLION) 35

CHART 12 GLOBAL COMPUTED TOMOGRAPHY MARKET FORECAST, 2018-2025 (USD MILLION) 36

CHART 13 GLOBAL MAGNETIC RESONANCE IMAGING MARKET FORECAST, 2018-2025 (USD MILLION) 37

CHART 14 GLOBAL NUCLEAR MEDICINE IMAGING MARKET FORECAST, 2018-2025 (USD MILLION) 38

CHART 15 GLOBAL NUCLEAR INFRARED SPECTROSCOPIC IMAGING MARKET FORECAST, 2018-2025 (USD MILLION) 40

CHART 16 GLOBAL ELECTROENCEPHALOGRAPHY MARKET FORECAST, 2018-2025 (USD MILLION) 41

CHART 17 GLOBAL MAGNETOENCEPHALOGRAPHY MARKET FORECAST, 2018-2025 (USD MILLION) 42

CHART 18 GLOBAL VOXEL BASED MORPHOMETRY MARKET FORECAST, 2018-2025 (USD MILLION) 43

CHART 19 GLOBAL IN VITRO DIAGNOSTICS MARKET FORECAST, 2018-2025 (USD MILLION) 44

CHART 20 GLOBAL NEUROINFORMATICS MARKET FORECAST, 2018-2025 (USD MILLION) 45

CHART 21 GLOBAL NEUROINFORMATICS MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 (%) 46

CHART 22 GLOBAL NEUROINFORMATICS MARKET BY GEOGRAPHICAL SEGMENTATION, 2025 (%) 46

CHART 23 NEURODIAGNOSTICS MARKET REVENUE IN NORTH AMERICA, 2018-2025 (USD MILLION) 48

CHART 24 NEURODIAGNOSTICS MARKET REVENUE IN EUROPE, 2018-2025 (USD MILLION) 50

CHART 25 NEURODIAGNOSTICS MARKET REVENUE IN ASIA PACIFIC, 2018-2025 (USD MILLION) 51

CHART 26 NEURODIAGNOSTICS MARKET REVENUE IN REST OF THE WORLD, 2018-2025 (USD MILLION) 52

CHART 27 GE HEALTHCARE: OVERVIEW SNAPSHOT 60

CHART 28 GE HEALTHCARE: BUSINESS UNITS 61

CHART 29 GE HEALTHCARE: GEOGRAPHIC PRESENCE 63

CHART 30 GE HEALTHCARE: SWOT ANALYSIS 64

CHART 31 HITACHI MEDICAL CORPORATION: OVERVIEW SNAPSHOT 66

CHART 32 HITACHI MEDICAL CORPORATION: BUSINESS UNITS 67

CHART 33 HITACHI MEDICAL CORPORATION: GEOGRAPHIC PRESENCE 69

CHART 34 HITACHI MEDICAL CORPORATION: SWOT ANALYSIS 70

CHART 35 SIEMENS AG: OVERVIEW SNAPSHOT 73

CHART 36 SIEMENS AG: BUSINESS UNITS 74

CHART 37 SIEMENS AG: GEOGRAPHIC PRESENCE 76

CHART 38 SIEMENS HEALTHINEERS: SWOT ANALYSIS 77

CHART 39 ROYAL PHILIPS.: OVERVIEW SNAPSHOT 82

CHART 40 ROYAL PHILIPS: BUSINESS UNITS 83

CHART 41 ROYAL PHILIPS: GEOGRAPHIC PRESENCE 83

CHART 42 PHILIPS HEALTHCARE: SWOT ANALYSIS 85

CHART 43 CANON MEDICAL SYSTEMS CORP.: OVERVIEW SNAPSHOT 87

CHART 44 CANON MEDICAL SYSTEMS CORP.: BUSINESS UNITS 88

CHART 45 CANON MEDICAL SYSTEMS CORP.: GEOGRAPHIC PRESENCE 89

CHART 46 CANON MEDICAL SYSTEMS CORP.: SWOT ANALYSIS 90

CHART 47 NIHON KOHDEN CORPORATION.: OVERVIEW SNAPSHOT 93

CHART 48 NIHON KOHDEN CORPORATION: BUSINESS UNITS 94

CHART 49 NIHON KOHDEN CORPORATION.: GEOGRAPHIC PRESENCE 95

CHART 50 NIHON KOHDEN CORPORATION.: SWOT ANALYSIS 96

?

TABLE 1 CLINICAL TRIALS OF NEUROINTERVENTIONAL DEVICES 22

TABLE 2 GLOBAL NEUROINFORMATICS MARKET REVENUE BY REGIONS, 2018-2025 (USD MILLION) 47

TABLE 3 OTHER PROMINENT VENDORS OF NEURODIAGNOSTICS MARKET 55

TABLE 4 GE HEALTHCARE: OFFERINGS 57

TABLE 5 GE HEALTHCARE: RECENT DEVELOPMENTS 58

TABLE 6 HITACHI MEDICAL CORPORATION: OFFERINGS 65

TABLE 7 HITACHI MEDICAL CORPORATION: RECENT DEVELOPMENTS 66

TABLE 8 SIEMENS HEALTHINEERS: PRODUCT OFFERINGS 71

TABLE 9 SIEMENS HEALTHINEERS: RECENT DEVELOPMENTS 72

TABLE 10 PHILIPS HEALTHCARE: PRODUCT OFFERINGS 78

TABLE 11 PHILIPS HEALTHCARE: RECENT DEVELOPMENTS 79

TABLE 12 CANON MEDICAL SYSTEMS CORP.: PRODUCT OFFERINGS 86

TABLE 13 CANON MEDICAL SYSTEMS CORP.: RECENT DEVELOPMENTS 86

TABLE 14 NIHON KOHDEN CORPORATION.: PRODUCT OFFERINGS 92

TABLE 15 NIHON KOHDEN CORPORATION: RECENT DEVELOPMENTS 92

TABLE 16 BRUKER CORPORATION: SNAPSHOT 99

TABLE 17 FONAR CORPORATION: SNAPSHOT 101

TABLE 18 NEURONEXUS TECHNOLOGIES: SNAPSHOT 102

TABLE 19 NEUSOFT MEDICAL SYSTEMS CO., LTD.: SNAPSHOT 103

TABLE 20 PLEXON INC.: SNAPSHOT 104

TABLE 21 LIFELINES NEURODIAGNOSTICS SYSTEMS, INC.: SNAPSHOT 105

TABLE 22 NATUS MEDICAL: SNAPSHOT 106

TABLE 23 NEURODX DEVELOPMENT: SNAPSHOT 107

?

GE Healthcare

Siemens Healthineers

Philips Healthcare

Canon Medical Systems Corporation

Hitachi Medical Corporation

Nihon Kohden Corporation

Fonar Corporation

Neusoft Medical Systems Co., Ltd.

NeuroNexus Technologies, Inc.

Lifelines Neurodiagnostic Systems, Inc.

NeuroDx Development

Bruker Corporation

Plexon Inc

Natus Medical Incorporated


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person